Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J Halts Study of Doribax Antibiotic on Higher Death Rate
J&J Halts Study of Doribax Antibiotic on Higher Death Rate
J&J Halts Study of Doribax Antibiotic on Higher Death Rate
Submitted by
admin
on January 6, 2012 - 11:50am
Source:
Bloomberg
News Tags:
JNJ
Doribax
antibiotics
Headline:
J&J Halts Study of Doribax Antibiotic on Higher Death Rate
Do Not Allow Advertisers to Use My Personal information
